Schepel Lotta Linnea, Kunnola Eva, Airaksinen Marja, Aronpuro Kirsi, Kvarnström Kirsi
HUS Pharmacy and Shared Group Services, HUS Helsinki University Hospital, Helsinki, Uusimaa, Finland
Faculty of Pharmacy, Division of Pharmacology and Pharmacotherapy, Clinical Pharmacy Group, University of Helsinki, Helsinki, Uusimaa, Finland.
Eur J Hosp Pharm. 2025 Aug 21;32(5):413-420. doi: 10.1136/ejhpharm-2024-004312.
Pharmacists' involvement in patient care became more common in Finnish hospitals during the period of 2011-2016. The first national survey was conducted in 2011 and repeated using the same method in 2016. This development was in accordance with patient safety policy initiatives and European hospital pharmacy statements. This study aimed to conduct the third national follow-up survey on hospital clinical pharmacy services in Finland in 2022 and compare the results with those in 2016.
The study was conducted in 2022 as a national online survey targeting hospital pharmacies (n=22) and smaller-scale, independently operating medicine dispensaries (n=23). Descriptive statistics and qualitative content analysis were used for the data analysis.
The response rate was 64% (n=29/45), accounting for 19/22 hospital pharmacies and 10/23 medicine dispensaries. Clinical pharmacy services were provided in 83% (n=24/29) of the responding units. The clinical pharmacy staff increased between 2017 and 2022 and services became more common, particularly at admission units (eg, emergency departments) and outpatient clinics. In some units (25%, n=6/24), services were also available in the evenings and in one unit during weekends. Similar to 2016, system-based medication safety risk management was also highlighted in this survey, and the first medication safety officer positions (n=8/24) were created. The most increased tasks were medication reviews and medication safety audits, while in 2016 the most increased task was medication reconciliation. Pharmacist participation in patient discharge had decreased. Despite the increasing prevalence of automation technology and pharmacy assistants, logistical tasks decreased only slightly.
Finnish hospital clinical pharmacy services have continued to expand in accordance with national and international guidelines, and have become increasingly concentrated on medication safety risk management. They currently engage in admission and outpatient units, but effort should also be put into discharge.
2011年至2016年期间，芬兰医院药剂师参与患者护理的情况变得更为普遍。2011年进行了首次全国性调查，并于2016年采用相同方法再次进行调查。这一发展符合患者安全政策倡议和欧洲医院药学声明。本研究旨在于2022年开展芬兰医院临床药学服务的第三次全国性随访调查，并将结果与2016年的结果进行比较。
该研究于2022年作为一项全国性在线调查开展，目标是医院药房（n = 22）和规模较小、独立运营的药品调剂室（n = 23）。数据分析采用描述性统计和定性内容分析。
回复率为64%（n = 29/45），包括19/22家医院药房和10/23家药品调剂室。83%（n = 24/29）的回复单位提供临床药学服务。2017年至2022年期间临床药学工作人员有所增加，服务也变得更为普遍，尤其是在入院科室（如急诊科）和门诊诊所。在一些科室（25%，n = 6/24），晚上也提供服务，有一个科室在周末也提供服务。与2016年类似，本次调查也强调了基于系统的用药安全风险管理，并设立了首批用药安全官员职位（n = 8/24）。增加最多的任务是用药评估和用药安全审核，而在2016年增加最多的任务是用药核对。药剂师参与患者出院工作的情况有所减少。尽管自动化技术和药房助理的普及率不断提高，但后勤任务仅略有减少。
芬兰医院临床药学服务继续按照国家和国际指南不断扩展，并且越来越集中于用药安全风险管理。目前这些服务在入院和门诊科室开展，但也应在出院环节加以努力。
